Trademark: 79332046
Word
BELEMSI
Status
Registered
Status Code
700
Status Date
Tuesday, November 7, 2023
Serial Number
79332046
Registration Number
7209332
Registration Date
Tuesday, November 7, 2023
Mark Type
4000
Filing Date
Friday, December 17, 2021
Published for Opposition
Tuesday, August 22, 2023

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Nov 11, 2023
Correction Transaction Received From Ib
Nov 7, 2023
Notice Of Registration Confirmation Emailed
Nov 7, 2023
Registered-Principal Register
Nov 6, 2023
Notification Of Possible Opposition - Processed By Ib
Nov 1, 2023
Teas Change Of Correspondence Received
Nov 1, 2023
Teas Change Of Domestic Representatives Address
Nov 1, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 1, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 1, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 1, 2023
Teas Change Of Owner Address Received
Aug 22, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 22, 2023
Published For Opposition
Aug 2, 2023
Notification Of Possible Opposition Sent To Ib
Aug 2, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 2, 2023
Notification Of Notice Of Publication E-Mailed
Jul 31, 2023
Notification Of Possible Opposition - Processed By Ib
Jul 18, 2023
Approved For Pub - Principal Register
Jul 14, 2023
Petition To Director Dismissed
Jul 14, 2023
Notice Of Reinstatement E-Mailed
Jul 12, 2023
Notification Of Possible Opposition Sent To Ib
Jul 12, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Jul 11, 2023
Assigned To Examiner
Jul 11, 2023
Reinstated
May 25, 2023
Assigned To Petition Staff
Feb 3, 2023
Teas Petition To Director Received
Feb 21, 2022
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Feb 20, 2022
Death Of International Registration
Feb 15, 2022
Application Filing Receipt Mailed
Feb 9, 2022
New Application Office Supplied Data Entered
Feb 2, 2022
Limitation From Original Application Entered
Jan 27, 2022
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24